Streetbeat News

SNES

SenesTech, Inc.

https://www.senestech.com

Industry

Chemicals - Specialty

SenesTech, Inc. develops a technology for managing animal pest populations through fertility control. It offers ContraPest, a liquid bait that limits reproduction of male and female rats. The company was incorporated in 2004 and is headquartered in Phoenix, Arizona.

Open

2.43

Mkt cap

2.3M

Volume

231K

High

2.43

P/E Ratio

0.02

52-wk high

9.80

Low

2.12

Div yield

N/A

52-wk low

1.90

SenesTech, Inc. (NASDAQ:SNES) has entered into an exclusive distribution agreement with Evicom to distribute its Evolve Soft Bait fertility control product in Australia and New Zealand. This partnership aims to address the demand for environmentally sustainable pest control solutions, particularly in response to Australia's rat plagues and New Zealand's efforts to eradicate invasive Norway rats by 2050. The agreement includes annual minimums and mandates Evicom to lead regulatory approvals in the target markets.

Portfolio Pulse from Benzinga Newsdesk

February 08, 2024 | 2:03 pm

Fortinet, Inc. (NASDAQ:FTNT) shares surged 9.4% in pre-market trading after reporting Q4 earnings and sales that exceeded analyst expectations, and providing strong 2024 revenue and EPS guidance. Other stocks also showed significant pre-market movements, including notable gainers like MariaDB plc (NYSE:MRDB) and losers such as Snap Inc. (NYSE:SNAP).

Portfolio Pulse from Avi Kapoor

February 07, 2024 | 12:55 pm

SenesTech, Inc. has entered into a distribution agreement with Poppe Enterprises. The specific terms of the agreement have not been disclosed to the public.

Portfolio Pulse from Benzinga Newsdesk

January 29, 2024 | 2:10 pm

SenesTech, Inc. has announced a partnership with a global leader in irrigation solutions to expand its Evolve soft bait fertility control solution into open field agriculture, starting with a California dairy and almond grower. Evolve aims to control rodent populations by reducing fertility rather than relying on poisons, which are restricted in California. This expansion into agriculture represents a significant market opportunity for SenesTech, as rodents destroy nearly 20% of the world's stored food supply.

Portfolio Pulse from Benzinga Newsdesk

January 08, 2024 | 2:19 pm

U.S. stocks saw a mixed performance with the Nasdaq Composite dropping significantly. Tesla Inc. (TSLA) reported higher-than-expected vehicle production and deliveries for Q4, surpassing consensus estimates. Health care shares gained, while information technology shares declined. Crude oil prices fell by 2.1%, and several companies experienced significant stock movements, including Longboard Pharmaceuticals (LBPH), Voyager Therapeutics (VYGR), and SenesTech (SNES) with notable gains, and Anavex Life Sciences (AVXL), LumiraDx (LMDX), and Corcept Therapeutics (CORT) with sharp declines.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 7:17 pm

Longboard Pharmaceuticals, Inc. (LBPH) shares soared by approximately 200% after announcing positive topline data from their PACIFIC Phase 1b/2a study of bexicaserin (LP352) for seizures associated with Developmental and Epileptic Encephalopathies (DEEs). Other stocks experienced significant movement in Tuesday's mid-day session, with various companies seeing substantial gains or losses.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 6:35 pm

In Tuesday's intraday session, several healthcare stocks experienced significant movements. Longboard Pharmaceuticals (LBPH) saw a 200.7% increase, while NGM Biopharmaceuticals (NGM) rose by 49.01%. Cardio Diagnostics Hldgs (CDIO) increased by 37.27%, SenesTech (SNES) by 33.07%, Cue Health (HLTH) by 29.29%, and VolitionRX (VNRX) by 27.32%. Conversely, Anavex Life Sciences (AVXL) fell by 34.5%, China SXT Pharmaceuticals (SXTC) by 29.98%, Corcept Therapeutics (CORT) by 28.19%, LumiraDx (LMDX) by 25.6%, RenovoRx (RNXT) by 24.9%, and Aditxt (ADTX) by 23.08%.

Portfolio Pulse from Benzinga Insights

January 02, 2024 | 5:31 pm

U.S. stocks traded mixed with the Dow Jones gaining and NASDAQ falling. Energy shares rose while information technology shares fell. Rivian Automotive reported lower-than-expected Q4 vehicle deliveries. Longboard Pharmaceuticals surged on positive study data, while Anavex Life Sciences plunged after an update on its Rett Syndrome program. LumiraDx fell after agreeing to sell its technology platform to Roche, and Corcept Therapeutics dropped due to a court decision favoring Teva Pharmaceuticals. Oil prices decreased, and gold prices saw a slight increase.

Portfolio Pulse from Avi Kapoor

January 02, 2024 | 5:15 pm

SenesTech, Inc. (NASDAQ:SNES) shares surged after announcing an expanded distribution agreement with Pesterminators Pvt Ltd, which includes the introduction of SenesTech's Evolve and market expansion into the UAE through Pesterminators' subsidiary, TCS Global for General Trading LLC. The expansion is part of SenesTech's regional growth strategy, following the successful integration of their ContraPest products in the Maldives. The agreement includes an initial stocking order for Evolve and an expanded territory that now includes the UAE. SNES shares rose 25.1% to $1.59.

Portfolio Pulse from Akanksha Bakshi

January 02, 2024 | 4:26 pm

SenesTech shares have risen following the announcement of an expanded distribution agreement with Pesterminators, which now includes the deployment of Evolve and an extension of territory into the UAE.

Portfolio Pulse from Benzinga Newsdesk

January 02, 2024 | 3:43 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.